Generation Green Formula
Natural health product licensed in Canada
- Licence holder
- Hardbody Supplements LLC
- NPN or DIN-HM
- 80107000
- Status
- Active licence
- Licence date
- 18 December 2020
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Brassica oleracea var. italica Source : Sommité | 100 mg | Not calculated |
| Carthamus tinctorius Source : Graine | 10 mg | Not calculated |
| Medicago sativa Source : Sommité | 500 mg | Not calculated |
| Eleutherococcus senticosus Source : Racine | 25 mg | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BI-04 | 5 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 34,000 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| Inuline Source : Helianthus tuberosus - tubercule | 1,015 mg | Not calculated |
| Ananas comosus var. comosus Source : Fruit | 20 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 40 mg Potency : 80 % Oligomeric proanthocyanidins | 10 mg | Not calculated |
| Malpighia glabra Source : Fruit | 115 mg | Not calculated |
| Taraxacum officinale Source : Plante entière | 10 mg | Not calculated |
| Fagopyrum esculentum Source : Graine | 75 mg | Not calculated |
| Lactiplantibacillus plantarum Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lp-115 | 5 Milliards d'UFC | Not calculated |
| Linum usitatissimum Source : Graine Potency : 12 % Linoleic acid | 100 mg | Not calculated |
| Spinacia oleracea Source : Feuille | 75 mg | Not calculated |
| Linum usitatissimum Source : Graine Potency : 35 % alpha-Linolenic acid | Not specified | Not calculated |
| Daucus carota Source : Racine | 200 mg | Not calculated |
| Beta vulgaris Source : Racine | 250 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
| Nasturtium officinale Source : Feuille | 15 mg | Not calculated |
| Chlorella vulgaris Source : Cellule brisée | 200 mg | Not calculated |
| Brassica oleracea var. viridis Source : Feuille | 35 mg | Not calculated |
| Borago officinalis Source : Graine | 20 mg | Not calculated |
Non-medicinal ingredients
Extrait de feuilles de stévia, Pédoncule et limbe de wakamé, Saveur de baies, Pectine, Jus de myrtille déshydraté, Acide DL-malique, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. Digestive enzyme(s). Helps to support liver function. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80107000
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.